Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer

Jun 03, 2019 9:00am EDT

Aptose Announces Closing of Public Offering of Common Shares

Jun 03, 2019 8:38am EDT

Aptose to Present at the Jefferies 2019 Healthcare Conference

May 31, 2019 8:00am EDT

Aptose Announces Pricing of Public Offering of Common Shares

May 30, 2019 9:01am EDT

Aptose Announces Proposed Public Offering of Common Shares

May 29, 2019 4:22pm EDT

Aptose Biosciences Establishes New At-The-Market Facility

May 24, 2019 5:43pm EDT

Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association

May 16, 2019 10:02am EDT

Aptose to Present at May Investor Conferences

May 13, 2019 8:15am EDT

Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC

May 10, 2019 7:24pm EDT

Aptose Reports Results for the First Quarter Ended March 31, 2019

May 07, 2019 4:01pm EDT